Barriers to insulin initiation: the translating research into action for diabetes insulin starts project.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 20086256.
- Also identified by DOI 10.2337/dc09-1184 and PMC identifier 2845015.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Reasons for failing to initiate prescribed insulin (primary nonadherence) are poorly understood. We investigated barriers to insulin initiation following a new prescription. We surveyed insulin-naïve patients with poorly controlled type 2 diabetes, already treated with two or more oral agents who were recently prescribed insulin. We compared responses for respondents prescribed, but never initiating, insulin (n = 69) with those dispensed insulin (n = 100). Subjects failing to initiate prescribed insulin commonly reported misconceptions regarding insulin risk (35% believed that insulin causes blindness, renal failure, amputations, heart attacks, strokes, or early death), plans to instead work harder on behavioral goals, sense of personal failure, low self-efficacy, injection phobia, hypoglycemia concerns, negative impact on social life and job, inadequate health literacy, health care provider inadequately explaining risks/benefits, and limited insulin self-management training. Primary adherence for insulin may be improved through better provider communication regarding risks, shared decision making, and insulin self-management training.
Medical subject headings
- Diabetes Mellitus, Type 2
- Insulin
- Medication Adherence
- Drug Monitoring